Kringle Pharma (4884) · InitiativeRestatedLatest Business Alliance (2026-09-16): "Advanced"
Building a Domestic Supply Chain with Maruishi Pharmaceutical and TOHO HOLDINGS CO.,LTD.
First written in FY2020. 3 of 5 entries say "Advanced", first in 2026-07-15. Latest entry: 2026-09-16.
5entries
7years
3from disclosures
How it moved
Same theme, other companies
Commercialization Model Through External Partnerships for Manufacturing and SalesA theme 8 companies write about · 0 as a headwind · 8 as a tailwind
3 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「脊髄損傷急性期を対象とした製品のサプライチェーンについては、現時点で当社内に営業販売体制がないことから、丸石製薬株式会社と東邦ホールディングス株式会社との提携により構築されております。」
自社の営業販売体制を持たず、丸石製薬と東邦ホールディングスの提携で国内サプライチェーンを構築する方針を再掲している。 - FY2020First statedAnnual report
「Because we currently do not have an in-house sales and marketing organization for products targeting acute spinal cord injury, the supply chain shown below has been established through partnerships with Maruishi Pharmaceutical Co., Ltd. and TOHO HOLDINGS CO.,LTD.」
Because the company does not have its own sales organization, Maruishi Pharmaceutical handles sales and promotion while TOHO HOLDINGS CO.,LTD. handles wholesale distribution.